Search - tctmd.com

Displaying 1 - 20 of 65

Sort: Relevancy | Date

News Features

Year in Review: DAPA-HF Tops Heart Failure News Amid Other Wins and Losses

Shelley Wood

December 23, 2019

News Industry News

Robocath Successfully Completes First Robotic Coronary Angioplasties in Africa

December 16, 2019

News Daily News

CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials

Caitlin E. Cox

December 11, 2019

Real-world Data Show MitraClip Benefit in COAPT-Ineligible Patients

Michael O'Riordan

November 17, 2019

News Conference News AHA 2019

ISCHEMIA: Invasive Strategy No Better Than Meds for CV Events

Shelley Wood

November 16, 2019

News Conference News VIVA 2019

Future Pulmonary Embolism Interventions: Wild West or Working Together?

L.A. McKeown

November 14, 2019

News Opinion Off Script AHA 2019

Off Script: Will ISCHEMIA Answer Our Most Pressing Questions?

Ajay Kirtane, MD, SM

November 12, 2019

News Conference News VIVA 2019

Clinicians Get Real on Radiation: ‘Don’t Do Dumb Things’

L.A. McKeown

November 07, 2019

News Industry News

Intact Vascular Announces Positive Six-Month Data from TOBA II BTK Clinical Trial During Late-Breaking Session at 2019 VIVA Conference

November 06, 2019

News Conference News TCT 2019

PICCOLETO II: More Support for DCB Safety and Efficacy in Small Coronaries

L.A. McKeown

October 04, 2019

News Conference News TCT 2019

FORZA: For Intermediate Lesions, OCT-Guided PCI Costs More, Yields Better Outcomes vs FFR

Caitlin E. Cox

October 01, 2019

Off Script: A (Not So) Brief History of Aspirin’s Rise and Fall

News Opinion Off Script TCT 2019

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

Kwan S. Lee

September 29, 2019

News Conference News TCT 2019

COAPT at 3 Years: Crossover Patients See Benefits From MitraClip

Shelley Wood

September 28, 2019

News Industry News

Intact Vascular Announces Positive One-Year Data from TOBA III Clinical Trial

September 27, 2019

News Industry News

Robocath Successfully Carries Out Its First Robotic Coronary Angioplasties in Humans

September 24, 2019

News Industry News

Robocath raises €5 million and announces the appointment of Lucien Goffart as new CEO

September 03, 2019

News Conference News ESC 2019

MITRA-FR at 2 Years: Still No Benefit of MitraClip Over Meds

Shelley Wood

September 02, 2019

News Daily News

VA Medical Centers’ Quality Measures for TAVR Pay Off

Caitlin E. Cox

August 30, 2019

News Daily News

Learning Curve for New CTO Operators: Some Reassurances, Some Caveats

L.A. McKeown

August 26, 2019

News Daily News

FDA Expands TAVR Indication to Low-Risk Patients

Michael O'Riordan

August 16, 2019

Advertisement

Year in Review: DAPA-HF Tops Heart Failure News Amid Other Wins and Losses

Robocath Successfully Completes First Robotic Coronary Angioplasties in Africa

CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials

Real-world Data Show MitraClip Benefit in COAPT-Ineligible Patients

ISCHEMIA: Invasive Strategy No Better Than Meds for CV Events

Future Pulmonary Embolism Interventions: Wild West or Working Together?

Off Script: Will ISCHEMIA Answer Our Most Pressing Questions?

Clinicians Get Real on Radiation: ‘Don’t Do Dumb Things’

Intact Vascular Announces Positive Six-Month Data from TOBA II BTK Clinical Trial During Late-Breaking Session at 2019 VIVA Conference

PICCOLETO II: More Support for DCB Safety and Efficacy in Small Coronaries

FORZA: For Intermediate Lesions, OCT-Guided PCI Costs More, Yields Better Outcomes vs FFR

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

COAPT at 3 Years: Crossover Patients See Benefits From MitraClip

Intact Vascular Announces Positive One-Year Data from TOBA III Clinical Trial

Robocath Successfully Carries Out Its First Robotic Coronary Angioplasties in Humans

Robocath raises €5 million and announces the appointment of Lucien Goffart as new CEO

MITRA-FR at 2 Years: Still No Benefit of MitraClip Over Meds

VA Medical Centers’ Quality Measures for TAVR Pay Off

Learning Curve for New CTO Operators: Some Reassurances, Some Caveats

FDA Expands TAVR Indication to Low-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content